{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:17Z","timestamp":1793831297950,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Open\nAccess funding enabled and organized by Projekt DEAL. Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EO1504"],"award-info":[{"award-number":["01EO1504"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008769","name":"Julius-Maximilians-Universit\u00e4t W\u00fcrzburg","doi-asserted-by":"publisher","award":["Publication Fund"],"award-info":[{"award-number":["Publication Fund"]}],"id":[{"id":"10.13039\/501100008769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In 2022, the definition of pulmonary hypertension (PH) in the presence of left heart disease was updated according to the new joint guidelines of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). The impact of the new ESC\/ERS definition on the prevalence of post-capillary PH (pc-PH) and its subgroups of isolated post-capillary (Ipc-PH) and combined pre- and post-capillary PH (Cpc-PH) in patients with left heart disease is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively identified\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009242 patients with left heart disease with available data on right heart catheterisation (RHC) and cardiac magnetic resonance imaging (CMR). The proportion of pc-PH and its subgroups was calculated according to the old and new ESC\/ERS PH definition. As the old definition did not allow the exact allocation of all patients with pc-PH into a respective subgroup, unclassifiable patients (Upc-PH) were regarded separately.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-six out of 242 patients had pc-PH according to the new ESC\/ERS definitions, with 72 of these patients also meeting the criteria of the old definition. Using the old definition, 50 patients were diagnosed with Ipc-PH, 4 with Cpc-PH, and 18 with Upc-PH. Applying the new definition, Ipc-PH was diagnosed in 35 patients (4 newly), and Cpc-PH in 41 patients. No CMR parameter allowed differentiating between Ipc-PH and Cpc-PH, regardless of which guideline version was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Applying the new ESC\/ERS 2022 guideline definitions mildly increased the proportion of patients diagnosed with pc-PH (+\u20095.5%) but markedly increased Cpc-PH diagnoses. This effect was driven by the allocation of patients with formerly unclassifiable forms of post-capillary PH to the Cpc-PH subgroup and a significant shift of patients from the Ipc-PH to the Cpc-PH subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-023-02290-5","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T06:02:48Z","timestamp":1693893768000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines"],"prefix":"10.1007","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-5359","authenticated-orcid":false,"given":"G\u00fclmisal","family":"G\u00fcder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Fette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Hundertmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"St\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"38","key":"2290_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Radegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, Group EESD (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"issue":"1","key":"2290_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"issue":"25 Suppl","key":"2290_CR3","doi-asserted-by":"publisher","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","volume":"62","author":"JL Vachiery","year":"2013","unstructured":"Vachiery JL, Adir Y, Barbera JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galie N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W (2013) Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 62(25 Suppl):D100-108. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.033","journal-title":"J Am Coll Cardiol"},{"key":"2290_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijcard.2018.08.080","volume":"272S","author":"S Rosenkranz","year":"2018","unstructured":"Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kubler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF (2018) Pulmonary hypertension associated with left heart disease: updated recommendations of the Cologne Consensus Conference 2018. Int J Cardiol 272S:53\u201362. https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.080","journal-title":"Int J Cardiol"},{"issue":"2","key":"2290_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1183\/13993003.00432-2016","volume":"48","author":"M Gerges","year":"2016","unstructured":"Gerges M, Gerges C, Lang IM (2016) How to define pulmonary hypertension due to left heart disease. Eur Respir J 48(2):553\u2013555. https:\/\/doi.org\/10.1183\/13993003.00432-2016","journal-title":"Eur Respir J"},{"issue":"2","key":"2290_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1183\/13993003.00854-2016","volume":"48","author":"N Galie","year":"2016","unstructured":"Galie N, Manes A, Palazzini M (2016) The difficult diagnosis of pulmonary vascular disease in heart failure. Eur Respir J 48(2):311\u2013314. https:\/\/doi.org\/10.1183\/13993003.00854-2016","journal-title":"Eur Respir J"},{"key":"2290_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01897-2018","author":"JL Vachiery","year":"2019","unstructured":"Vachiery JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, Coghlan G, Chazova I, De Marco T (2019) Pulmonary hypertension due to left heart disease. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01897-2018","journal-title":"Eur Respir J"},{"issue":"Suppl K","key":"2290_CR8","doi-asserted-by":"publisher","first-page":"K4","DOI":"10.1093\/eurheartj\/suz211","volume":"21","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Hoeper MM (2019) The revised definition of pulmonary hypertension: exploring the impact on patient management. Eur Heart J Suppl 21(Suppl K):K4\u2013K8. https:\/\/doi.org\/10.1093\/eurheartj\/suz211","journal-title":"Eur Heart J Suppl"},{"issue":"9","key":"2290_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s00392-018-1245-z","volume":"107","author":"M Kaspar","year":"2018","unstructured":"Kaspar M, Fette G, Guder G, Seidlmayer L, Ertl M, Dietrich G, Greger H, Puppe F, Stork S (2018) Underestimated prevalence of heart failure in hospital inpatients: a comparison of ICD codes and discharge letter information. Clin Res Cardiol 107(9):778\u2013787. https:\/\/doi.org\/10.1007\/s00392-018-1245-z","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"2290_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/CRD.0000000000000223","volume":"27","author":"EE Argueta","year":"2019","unstructured":"Argueta EE, Paniagua D (2019) Thermodilution cardiac output: a concept over 250 years in the making. Cardiol Rev 27(3):138\u2013144. https:\/\/doi.org\/10.1097\/CRD.0000000000000223","journal-title":"Cardiol Rev"},{"issue":"3","key":"2290_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(3):233\u2013270. https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"2290_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","volume":"22","author":"CM Kramer","year":"2020","unstructured":"Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E (2020) Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 22(1):17. https:\/\/doi.org\/10.1186\/s12968-020-00607-1","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"2290_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/heartjnl-2014-306142","volume":"101","author":"RR Vanderpool","year":"2015","unstructured":"Vanderpool RR, Pinsky MR, Naeije R, Deible C, Kosaraju V, Bunner C, Mathier MA, Lacomis J, Champion HC, Simon MA (2015) RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 101(1):37\u201343. https:\/\/doi.org\/10.1136\/heartjnl-2014-306142","journal-title":"Heart"},{"issue":"21","key":"2290_CR14","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/circulationaha.121.054858","volume":"144","author":"MK Burrage","year":"2021","unstructured":"Burrage MK, Hundertmark M, Valkovic L, Watson WD, Rayner J, Sabharwal N, Ferreira VM, Neubauer S, Miller JJ, Rider OJ, Lewis AJM (2021) Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction. Circulation 144(21):1664\u20131678. https:\/\/doi.org\/10.1161\/circulationaha.121.054858","journal-title":"Circulation"},{"issue":"138","key":"2290_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1183\/16000617.0062-2015","volume":"24","author":"S Rosenkranz","year":"2015","unstructured":"Rosenkranz S, Preston IR (2015) Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev 24(138):642\u2013652. https:\/\/doi.org\/10.1183\/16000617.0062-2015","journal-title":"Eur Respir Rev"},{"issue":"5","key":"2290_CR16","first-page":"303","volume":"5","author":"D Dubois","year":"1989","unstructured":"Dubois D, Dubois EF (1989) Nutrition metabolism classic\u2014a formula to estimate the approximate surface-area if height and weight be known (Reprinted from Archives Internal Medicine, Vol 17, Pg 863, 1916). Nutrition 5(5):303\u2013311","journal-title":"Nutrition"},{"issue":"36","key":"2290_CR17","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESCSD (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"3","key":"2290_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ejhf.1741","volume":"22","author":"B Pieske","year":"2020","unstructured":"Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G (2020) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 22(3):391\u2013412. https:\/\/doi.org\/10.1002\/ejhf.1741","journal-title":"Eur J Heart Fail"},{"key":"2290_CR19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02148-2018","author":"N Galie","year":"2019","unstructured":"Galie N, McLaughlin VV, Rubin LJ, Simonneau G (2019) An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.02148-2018","journal-title":"Eur Respir J"},{"key":"2290_CR20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01913-2018","journal-title":"Eur Respir J"},{"issue":"4","key":"2290_CR21","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1183\/09031936.00145608","volume":"34","author":"G Kovacs","year":"2009","unstructured":"Kovacs G, Berghold A, Scheidl S, Olschewski H (2009) Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34(4):888\u2013894. https:\/\/doi.org\/10.1183\/09031936.00145608","journal-title":"Eur Respir J"},{"issue":"1","key":"2290_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jchf.2014.07.010","volume":"3","author":"E Tampakakis","year":"2015","unstructured":"Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ (2015) The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 3(1):9\u201316. https:\/\/doi.org\/10.1016\/j.jchf.2014.07.010","journal-title":"JACC Heart Fail"},{"issue":"1","key":"2290_CR23","doi-asserted-by":"publisher","first-page":"204589401881543","DOI":"10.1177\/2045894018815438","volume":"9","author":"D Aronson","year":"2019","unstructured":"Aronson D, Hardak E, Burger AJ (2019) Hemodynamics of the diastolic pressure gradients in acute heart failure: implications for the diagnosis of pre-capillary pulmonary hypertension in left heart disease. Pulm Circ 9(1):2045894018815438. https:\/\/doi.org\/10.1177\/2045894018815438","journal-title":"Pulm Circ"},{"key":"2290_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-022-10251-9","author":"M Riccardi","year":"2022","unstructured":"Riccardi M, Pagnesi M, Sciatti E, Lombardi CM, Inciardi RM, Metra M, Vizzardi E (2022) Combined pre- and post-capillary pulmonary hypertension in left heart disease. Heart Fail Rev. https:\/\/doi.org\/10.1007\/s10741-022-10251-9","journal-title":"Heart Fail Rev"},{"issue":"9","key":"2290_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","volume":"8","author":"BA Maron","year":"2020","unstructured":"Maron BA, Brittain EL, Hess E, Waldo SW, Baron AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Galie N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G (2020) Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med 8(9):873\u2013884. https:\/\/doi.org\/10.1016\/S2213-2600(20)30317-9","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2290_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.00008611","volume":"39","author":"G Kovacs","year":"2012","unstructured":"Kovacs G, Olschewski A, Berghold A, Olschewski H (2012) Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 39(2):319\u2013328. https:\/\/doi.org\/10.1183\/09031936.00008611","journal-title":"Eur Respir J"},{"key":"2290_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2021.04.006","volume":"335","author":"E Pfeuffer-Jovic","year":"2021","unstructured":"Pfeuffer-Jovic E, Weiner S, Wilkens H, Schmitt D, Frantz S, Held M (2021) Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension. Int J Cardiol 335:105\u2013110. https:\/\/doi.org\/10.1016\/j.ijcard.2021.04.006","journal-title":"Int J Cardiol"},{"key":"2290_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac387","author":"J Bauersachs","year":"2022","unstructured":"Bauersachs J, Olsson KM (2022) Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development? Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehac387","journal-title":"Eur Heart J"},{"key":"2290_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijcard.2018.09.043","volume":"273","author":"JY Cao","year":"2018","unstructured":"Cao JY, Wales KM, Cordina R, Lau EMT, Celermajer DS (2018) Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: a meta-analysis. Int J Cardiol 273:213\u2013220. https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.043","journal-title":"Int J Cardiol"},{"issue":"1","key":"2290_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcmg.2014.12.003","volume":"8","author":"J Magne","year":"2015","unstructured":"Magne J, Pibarot P, Sengupta PP, Donal E, Rosenhek R, Lancellotti P (2015) Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging 8(1):83\u201399. https:\/\/doi.org\/10.1016\/j.jcmg.2014.12.003","journal-title":"JACC Cardiovasc Imaging"},{"issue":"15","key":"2290_CR31","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","volume":"39","author":"J Bermejo","year":"2018","unstructured":"Bermejo J, Yotti R, Garcia-Orta R, Sanchez-Fernandez PL, Castano M, Segovia-Cubero J, Escribano-Subias P, San Roman JA, Borras X, Alonso-Gomez A, Botas J, Crespo-Leiro MG, Velasco S, Bayes-Genis A, Lopez A, Munoz-Aguilera R, de Teresa E, Gonzalez-Juanatey JR, Evangelista A, Mombiela T, Gonzalez-Mansilla A, Elizaga J, Martin-Moreiras J, Gonzalez-Santos JM, Moreno-Escobar E, Fernandez-Aviles F (2018) Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. Eur Heart J 39(15):1255\u20131264. https:\/\/doi.org\/10.1093\/eurheartj\/ehx700","journal-title":"Eur Heart J"},{"issue":"20","key":"2290_CR32","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O\u2019Connor CM, Group VS (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382(20):1883\u20131893. https:\/\/doi.org\/10.1056\/NEJMoa1915928","journal-title":"N Engl J Med"},{"issue":"11","key":"2290_CR33","doi-asserted-by":"publisher","first-page":"e020633","DOI":"10.1161\/JAHA.120.020633","volume":"10","author":"C Lteif","year":"2021","unstructured":"Lteif C, Ataya A, Duarte JD (2021) Therapeutic challenges and emerging treatment targets for pulmonary hypertension in left heart disease. J Am Heart Assoc 10(11):e020633. https:\/\/doi.org\/10.1161\/JAHA.120.020633","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2290_CR34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/eurheartj\/ehad018","volume":"44","author":"S Rosenkranz","year":"2023","unstructured":"Rosenkranz S, Delcroix M, Giannakoulas G, Hoeper MM, Kovacs G, Humbert M (2023) The \u2018Ten Commandments\u2019 of the 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 44(10):792\u2013793. https:\/\/doi.org\/10.1093\/eurheartj\/ehad018","journal-title":"Eur Heart J"},{"issue":"2","key":"2290_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/heartjnl-2015-307786","volume":"102","author":"P Callan","year":"2016","unstructured":"Callan P, Clark AL (2016) Right heart catheterisation: indications and interpretation. Heart 102(2):147\u2013157. https:\/\/doi.org\/10.1136\/heartjnl-2015-307786","journal-title":"Heart"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02290-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:58:26Z","timestamp":1770796706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02290-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2290"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02290-5","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"20 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval of the ethical committee was waived, as the Data Ware House runs on standard operating procedures that are controlled and approved by the institution's data protection officer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}